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Summary We have investigated X-ray survival parameters and repair of potentially lethal damage (PLDR)
in ten early passage squamous cell carcinoma cell lines derived from patients who were biopsied before
initiation of radiotherapy or after radiation therapy failure.
Radiosensitivity (Do) ranged from 1.07 to 1.93 (Gy), extrapolation numbers (fi) from 1.17 to 2.14 and PLD
recovery at 24h from 1.4 to 20.3. Despite significant differences in these parameters amongst the cell lines, a
firm correlation between radiocurability and any individual radiobiological parameter could not be
established. Our data suggest that the mechanisms associated with radioresistance are complex and that any
single radiobiological parameter may not predict clinical success or failure.
Ionizing radiation has become an integral part of
human cancer therapy, although the biological
explanation for therapeutic success or failure
remains elusive. Radiotherapy delivered in multiple
small doses (1.5-3.0Gy day-1) has been found to
have a higher therapeutic ratio than radiation
delivered as a large single dose (Tubiana, 1983).
Attempts to explain the advantage of fractionation
as well as the cause of failure of radiation
treatment in certain clinical circumstances have
invoked a variety of mechanisms. These include
redistribution of cells within the cell cycle following
radiation, the presence of hypoxic tumour cells, and
the reoxygenation of these cells. While investigation
of the latter two factors has yielded interesting
information in animal tumour systems, cell hypoxia
as the major determinant of radiation failure in
human cancer has not been established (Denekamp,
1983).
Another area of interest in radiobiology is the
study of the intrinsic X-ray sensitivity or resistance
of tumour cells and the repair of sublethal and
potentially lethal X-ray damage. It has been
demonstrated that when a single dose of X-rays is
divided into two fractions separated by an interval
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of several hours, an enhancement in survival
occurs. This split dose recovery phenomenon has
been interpreted as reflecting the repair of sublethal
radiation damage induced by the first dose in cells
that survive this dose (Elkind, 1959). The
magnitude of this effect can be expressed by the
extrapolation number (n) which is the back extra-
polation of the slope to the ordinate (the shoulder
of the survival curve); the shoulder is thought to
represent the ability of cells to accumulate sublethal
X-ray injury (Elkind, 1976).
When monolayer cultures of mammalian cells are
maintained under conditions of constant medium
renewal without subculture, they enter a crowded,
density-inhibited state of growth in which the
fraction of dividing cells is reduced and a large
population of nonproliferating cells accumulates
(Little, 1969). This is an experimental condition
which may resemble the physiological state of
tumour cell populations in vivo since these may
contain a large population of nondividing but
potentially clonogenic cells. When such plateau
phase cultures are treated with X-rays or chemical
agents and subculture of the cells is delayed, an
enhancement in survival occurs. This phenomenon
has been referred to as recovery from potentially
lethal X-ray damage, and may be analogous to
liquid-holding recovery in bacteria and yeast (Little,
1969; Hahn & Little, 1972). PLDR has been
described in experimental solid and ascites tumours
as well as in established human tumour cell lines
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(Little et al., 1973; Weichselbaum et al., 1982;
Guichard et al., in press).
Experimental evidence indicates that many
established human tumour cell lines in culture are
not intrinsically more sensitive or resistant to the
lethal effects of X-rays than are cells obtained from
normal tissues (Weichselbaum et al., 1980; Smith et
al., 1978; Weininger et al., 1978). Exceptions have
been reported, however; Weichselbaum et al. (1982)
described an inherently radioresistant melanoma
line and Gerweck et al. (1977) and Nilsson et al.
(1980) reported several radioresistant glioblastoma
lines. Unusual repair parameters have been
reported in some human tumor cell lines as well.
For example, Barranco et al. (1971) reported
melanoma lines with large shoulders (i), and
Carney et al. (1983) investigated two large cell lung
carcinoma lines with relatively large extrapolation
numbers, although much smaller than those
reported by Barranco et al. (1971). for their
melanoma lines. Selby & Courtenay (1982) reported
a large shoulder for two human melanoma xeno-
grafts grown in agar diffusion chambers. Courtenay
et al. (1976) found a xenografted human pancreatic
carcinoma proficient in the repair of potentially
lethal damage. Weichselbaum et al. (1982) studied
two human melanoma cell lines and one osteo-
sarcoma line which were especially proficient in the
repair of potentially lethal X-ray damage. Both
groups suggested that one factor in the failure of
X-rays to sterilize a malignant tumour could be the
ability of noncycling cells to recover from
potentially lethal damage. Rofstad & Brustad
(1981) reported a human melanoma line proficient
in both sublethal and potentially lethal damage
repair. It should be noted, however, that all of
these studies were carried out on cell lines passaged
many times in vitro, and for none was the clinical
outcome of the patient from whom the line was
derived known.
In order to determine the possible contribution of
cellular radiosensitivity, sublethal and potentially
lethal damage repair in head and neck cancer
therapy, we studied 10 early passage tumour cell
populations derived from patients with head and
neck squamous cell carcinoma. Five biopsies were
obtained from patients before the institution of
therapy and 5 from patients who suffered radiation
failures. Our study is unique in that cell
populations from each tumour were serially
cultivated under identical conditions and were
studied between 10 and 15 passages after initial
explant, and correlation with clinical (radio-
curability) results was possible. We determined X-
ray survival parameters including ni and Do as well
as repair of potentially lethal X-ray damage for
these tumours in culture.
Materials and methods
Isolation oftumour cells
Methods of establishment and characterization of
squamous cell carcinoma lines have been published
(Rheinwald & Beckett, 1980, 1981) and are briefly
summarized here. Biopsies of squamous cell
carcinoma were obtained from patients seen in the
multidisciplinary head and neck tumour clinic at
the Dana-Farber Cancer Institute (DFCI) and the
Joint Center for Radiation Therapy (JCRT).
Culture conditions and procedures were similar to
those for preparing keratinocyte cultures from
normal skin, including co-culture with a 3T3 fibro-
blast feeder layer (Rheinwald, 1980). Biopsies were
placed immediately into culture medium within 2h
of removal. Samples were rinsed with serum-free
medium containing penicillin or streptomycin and
cut into pieces 3mm in diameter. A portion was
sectioned and stained with Haematoxylin and Eosin
in order to confirm that the biopsies contained
squamous cell carcinoma. The remaining fragments
were minced with scissors into pieces <1 mm in
diameter and were distributed to culture dishes and
held to the surface with a small plasma clot. One
day after plating, mitomycin C-treated, Swiss
mouse embryonic fibroblast 3T3 cells were added as
a feeder layer.
Growth medium consisted of Dulbecco's
modified Eagle's medium, 20% foetal calf serum,
and 0.4 ugml-' hydrocortisone. Primary cultures
were subcultured after 1-2 weeks, at which time
individual explant colonies had attained a diameter
of 0.5cm-l.0cm, and before neighboring colonies
had merged to make a confluent monolayer.
Tumour cell populations were disaggregated by a
15-30min incubation with 0.05% Trypsin plus
0.02% EDTA at 370 and were serially passaged at
7-10 day intervals by subculturing preconfluent
cultures that had been initiated from 1-
3 x 104cells/60ml dish together with 3T3 feeder
cells. Each passage was equivalent to about 7-10
cell generations. As reported previously (Rheinwald
& Beckett, 1981), the tumour lines retained unique
aneuploid karyotypes and distinctive morphological
characteristics indefinitely from the first passage,
suggesting that the lines represent the major stem
cell population of their respective tumours.
Tumours from the oral cavity grew with a higher
frequency of success than from other head and neck
sites (Rheinwald et al., 1983).
Radiation experiments
X-ray survival curves were determined as follows.
Cells at the 8th to 10th passages were maintained in
medium without 3T3 cells at 37°C in a humidifiedCELLULAR X-RAY REPAIR PARAMETERS 597
atmosphere of 5% CO2 in air. Cells were
trypsinized with 0.05% trypsin from stock cultures
and between 500 and 40,000 cells were plated in
10cm diameter dishes and allowed to enter
exponential growth. Radiation was carried out 18h
later with a GE Maximar X-ray generator at
220Kvp and 15MA yielding a dose rate of 0.8Gy
min- . Immediately after radiation the cultures
were returned to the incubator. After 18-24 days,
the cells were fixed and stained with Crystal violet.
Only colonies of >50 cells were scored as
survivors. All data points are the results of 2-4
experiments. Radiation survival curve parameters
measured are the Do, which is the inverse of the
slope of the radiation survival curve, and the extra-
polation number (n) which is the back extrapolation
of the slope to the ordinate. These parameters were
determined by a least squares regression analysis of
all data points.
PLDR studies were performed as follows. Cells
were initially seeded into 60mm plastic petri dishes
and grown to confluency. Culture medium was
renewed daily for 3 days and experiments
performed on the fourth. Cells were irradiated at
room temperature and afterwards were returned to
the incubator. Single dishes were removed and cells
subcultured and seeded at low density (10,000-
80,000 cells) at regular intervals thereafter.
Seven Gy was used to study PLD recovery.
Initial (0h subculture) surviving fractions were
similar in 8 of the 10 cell lines. SCC-61 and SCC-73
were exceptions and showed lower initial surviving
fractions than the other cell lines studied. The
enhancement in survival, as measured by the factor
of increased colony-forming ability resulting from
delay in subculture after irradiation, is interpreted
as being due to the repair of potentially lethal
damage. PLDR is expressed in terms of
enhancement in surviving fraction as a function of
time interval between radiation and subculture after
a single dose of radiation and is expressed as a
recovery ratio (R/Ro) by dividing the 24h surviving
fraction (R) by the Oh surviving fraction (RO).
Although growth of some of the cell lines was
greatly enhanced by the use of feeder layer support,
survival curve parameters were independent of the
presence of a feeder layer. Feeder layers used in
radiation experiments were reproductively
inactivated with 100Gy from a 2Ci Cobalt-60
source.
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Results
Table I shows a summary of clinical stage, site, and
response to radiotherapy in patients who suffered
local radiation failures. All patients had completed
a course of radiation therapy undertaken with
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curative intent. Portal films or charts were reviewed
when available to certify that tumours were in-field
failures and not marginal recurrences, the result of
technical errors or excessively protracted fractiona-
tion. Table II shows n-, Dog plating efficiency and
24h recovery ratio (PLDR) in tumour cells derived
from patients who suffered local radiation failures.
Twenty-four hour recovery ratio (R/RO) represents
the amount of PLDR performed by each cell line
Do's (radiosensitivity) ranged from 1.20-1.84 Gy
(mean 1.58 Gy). Extrapolation numbers (n) ranged
from 1.49-2.11 (mean 1.66). PLD recovery ratio
ranged from 1.4-6.2.
Table II Radiobiological parameters of cells from
patients who failed radiation therapy
24h R/Ro
Cell line N DO(Gy±s.e.) (PLDR) P.E.(%)
SCC-4 1.49 1.69+0.15 4.4 8.5-15.2
SCC-25 1.53 1.42+0.01 6.2 7.2-17.8
SCC-35 1.63 1.84+0.19 *1.4 21.6-55.7
SCC-13 2.11 1.28+0.07 2.2 13.8-19.1
SCC-49 1.55 1.70+0.12 4.9 11.7-17.2
X= 1.66 1.58 3.8
Table III shows a summary of clinical stage, site
and response to radiotherapy as well as local
control (radiocurability) in patients who had a
biopsy prior to radiotherapy delivered with curative
intent. One patient had chemotherapy and one
patient had surgery prior to the initiation of
radiation. Local control results were assessed in the
multidisciplinary JCRT-DFCI head and neck clinic
and recurrent tumours were proven by biopsy. One
patient died of a myocardial infarction; he showed
no histological evidence of tumour at autopsy.
Table IV shows a summary of ni, Do (radiosensi-
tivity) plating efficiencies, and 24h recovery ratio
(PLDR) in cells derived from tumours in which
biopsy was obtained before initiation of treatment.
Dos ranged from 1.07-1.60 Gy with a mean of 1.27
Gy and n ranged from 1.17-2.14 with a mean of
1.60. The 24h PLD recovery ratio ranged from 2.7-
20.3 with a mean of 8.1. The mean Do for all 10
cell lines was 1.43 Gy and the mean n was 1.63.
Figure 1 shows representative X-ray survival
curves for the most radiosensitive and radioresis-
tant cells in our study. SCC-35 was the most
resistant (Do= 1.84Gy) whereas SCC-61 was the
most radiosensitive (DO=1.07Gy). Figure 2 shows
the repair of potentially lethal X-ray damage in cell
lines that did the most and least PLD repair in our
study. Line SCC-35 did the least PLDR, (1.4 fold
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Table IV Radiobiological parameters of cells derived
from patients prior to radiation therapy
24h R/Ro
Cell line N DO(Gy±s.e.) (PLDR) P.E.(%)
SCC-9 1.39 1.34+0.01 7.1 4.9-12.9
SCC-61 1.83 1.07+0.02 20.3 6.0-18.3
SCC-73 1.17 1.08+0.04 9.3 3.6-12.0
SCC-71 1.45 1.60+0.20 2.3 4.0-36.8
SCC-66 2.14 1.29+0.15 2.7 0.65-14.3
X= 1.60 1.27 8.3
0
0)
U1)
Dose (Gy)
Figure 1 Representative X-ray survival curves for the
most radiosensitive (0) and radioresistant (0) cells.
recovery in 24h) whereas line SCC-61 did the most
PLDR, (20.3 recovery fold in 24h).
Discussion
The contribution of inherent cellular sensitivity and
cellular repair mechanisms to the clinical radio-
curability (local control) of human tumours is
unknown. Almost all radiobiological data on
human cells have been obtained from established
tumour lines passaged extensively in tissue culture
without knowledge of whether or not the tumour
had been locally controlled with therapy. This is the
first report to examine well-characterized early
passage clonogenic tumour cells for which clinical
outcome (local control) is known.
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Figure 2 Repair ofpotentially lethal X-ray damage in
cell lines that did the most (0) and least (0) PLD
repair.
Among cells derived from tumours that failed
radiotherapy, line SCC-35 was radioresistant,
(Do=1.84Gy) and lines SCC-4 and SCC-49 (Do
1.69Gy, 1.70Gy) were above the mean
(Do= 1.43 Gy). The other two cell lines derived
from patients who failed radiotherapy were inter-
mediate in their radiosensitivity Do= 1.28Gy-
1.42Gy. Three cell lines derived from patients who
failed radiation were intermediate in their ability to
perform PLDR (SCC-4, SCC-25, SCC-49), and two
lines (SCC-35 and SCC-13) were relatively deficient
in this ability (Table II). Although line SCC-13 was
modestly radiosensitive and did not perform much
PLDR, its extrapolation number was (with SCC-66)
the largest examined in this series. Any
enhancement in survival in the low dose region of
the survival curve would be magnified greatly in a
multifractionated treatment regimen, although it is
not known whether the larger extrapolation number
seen here is biologically significant. It may be that
this tumour failed on a stochastic basis, or the
clone of cells responsible for radiotherapeutic
failure did not grow in tissue culture. It should be
noted that line SCC-66, which grew from a pre-
treatment biopsy of a tumour that failed radiation,
also had a relatively large extrapolation number
(n-=2.14) compared to other lines examined here
(Table IV).
Data from animal tumour systems suggest that
cells derived from tumours that fail radiation
therapy are more radiosensitive than those studied
before treatment (Ando et al., 1983; Suit, 1966).
The Dos we determined for 5 cell line cultures from
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recurrent tumours in the present study were not
usually radiosensitive and, in fact, were more radio-
resistant as a group when the entire group of
patients is considered. Although we have studied
only a small sample of radiotherapeutic failures in
one class of human tumours, it may be that
resistant clones pre-exist in some tumours and
account for such failures.
Among cell lines derived from patients before
treatment with radiotherapy, two lines (SCC-61 and
SCC-73) were radiosensitive (Do= 1.07 and 1.08Gy)
and two lines (SCC-9 and SCC-66) were of
intermediate sensitivity (Do= 1.34 and 1.29Gy).
Three lines (SCC-9, SCC-61, and SCC-73) were
extremely proficient in PLDR, and two lines (SCC-
71 and SCC-66) were relatively deficient in this
repair process (Table IV).
Although inherent radioresistance characterized
by an elevated Do (greater than 1.43Gy) was
associated with therapeutic failure in 4/8 patients,
other factors such as the repair of potentially lethal
and sublethal X-ray damage may also have been
important. For example, line SCC-61, the most
radiosensitive cell line in our group but the most
proficient in PLDR, was derived from a tumour
that failed radiotherapy. This tumour was unusual
in that it grew through standard fractionation
(enlarged at 2Gyday-1). Treatment was then
altered to 1 Gy 3 times per day and resulted in a
decrease but not a complete regression of the mass.
Similarly, the tumour that yielded SCC-25 "grew
through" standard fractionation requiring
alteration in the treatment regimen, and SCC-25
was also proficient in PLDR in culture. On the
other hand, lines SCC-9 and SCC-13 were
proficient in PLDR, but the tumours of origin were
successfully treated by radiation therapy. Interpre-
tation is also complicated by the fact that one
patient had an excellent response to chemotherapy
prior to radiotherapy and another patient had
surgical excision of the primary lesion after pre-
operative radiotherapy which was followed by post-
operative radiotherapy. In these cases, cell
populations proficient in PLDR may have been
removed or PLDR may not have been expressed in
the tumours in these individuals.
Conditions that influence the repair of PLD in
vitro may differ from those in vivo. For example,
treatment of a tumour with X-rays or other cyto-
toxic agents is known to stimulate cell proliferation
and repopulation (Kallman et al., 1980; Hermans &
Barendsen, 1978). If proliferation occurs at early
time periods after radiation, much potentially lethal
damage repair may not be expressed since prolifer-
ation may fix damage and potentially lethal damage
converted to lethal damage (perhaps analogous to
early subculture points (0-2h) in vitro). If
proliferation begins at much later times (24-100h),
fixation of damage may not occur and PLDR may
proceed in cells genetically competent to do so.
Thus, differing amounts of PLDR may occur early
and late during a multifraction treatment course
depending upon the amount of proliferation
stimulated by the initial doses of radiation. Also,
extracellular factors such as oxygenation, pH, and
cellular nutrition may effect the fixation of
potentially lethal lesions.
Tang & Smith (1981) and Smith (personal
communication) suggested that bacterial cell strains
which are deficient in recombination but proficient
in the excision repair pathway of UV light are the
most proficient in liquid-holding recovery
(analogous to PLDR). An analogous situation
might occur in human tumour cell populations, in
that cells deficient in an X-ray repair process in
exponential growth exhibit repair proficiency in
plateau phase cultures. In this context, it is
interesting to note that the two most radiosensitive
lines in our study (lowest Do in exponential culture)
did the most PLDR (in plateau phase cultures).
The above data may have therapeutic
implications. For example, for cell lines that are
radioresistant and express their maximal recovery
instantaneously as radioresistance, a "true" radio-
sensitizer such as BUDR may merit clinical investi-
gation since it may directly sensitize resistant
tumour cells. However, in cells which express their
maximal recovery repair over a period of hours,
compounds such as l-B-D-Arabinofuranosylcyto-
sine (ara-C) 9-B-D-Arabinofuranosyladenine
(ara-A) and 3-aminobenzamide, which have been
shown to inhibit the repair of potentially lethal
damage in culture may prove effective in decreasing
cellular recovery between fractions of radiation
(Nakatsugawa & Sugahara, 1980; Nakatsugawa et
al., 1982; Illiakis, 1980; J.M. Brown, personal
communication, 1983).
The extrapolation numbers (0) in our series are
consistent with those seen for most established
human cell lines (Smith et al., 1978; Weininger et
al., 1978, 1980). Very large extrapolation numbers
have been reported for certain tumours such as
melanoma (Barranco et al., 1971; Selby &
Courtenay, 1982) which are typically radio-
incurable. It is of interest that cell lines with the
two largest n's in our study were cultured from
tumours that failed radiation treatment.
Although differences in n, Dog and PLDR are
demonstrable among the cell lines reported here, it
is not possible to draw firm conclusions about the
role of the various repair mechanisms in clinical
radiotherapy based on our limited study. Our data
suggest that Do alone may not predict therapeutic
success or failure and that an assay based only on
this parameter would be misleading as a predictor
ofclinical results.CELLULAR X-RAY REPAIR PARAMETERS 601
We know of no other in vitro radiobiological
data where early passage tumour cells have been
obtained from patients with a known clinical
outcome. Perhaps investigation of greater numbers
of tumours in culture and correlation with clinical
results will aid in scientific modification of clinical
fractionation schemes and predictability of thera-
peutic success or failure.
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